Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
17.06.25
/
50%
€46.40
Target price
17.06.26
€62.32
Performance (%)
112.28%
End price
18.06.26
€98.50
Summary
This prediction ended on 18.06.26 with a price of €98.50. The BUY prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc saw massive gains of 112.28%. Citigroup_Inc_ has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 2.542% | 2.542% | 155.274% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
177.52%
28.07.26
28.07.26
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€124.00
17.07.26
17.07.26
-
17.07.27
17.07.27
-2.42%
28.07.26
28.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€108.80
19.03.27
19.03.27
37.50%
28.07.26
28.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€74.00
10.11.25
10.11.25
€84.79
10.11.26
10.11.26
63.51%
28.07.26
28.07.26